Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Net Income: 2016-2025

Historic Net Income for Assembly Biosciences (ASMB) over the last 9 years, with Sep 2025 value amounting to -$9.2 million.

  • Assembly Biosciences' Net Income rose 4.34% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.2 million, marking a year-over-year increase of 4.03%. This contributed to the annual value of -$40.2 million for FY2024, which is 34.38% up from last year.
  • Per Assembly Biosciences' latest filing, its Net Income stood at -$9.2 million for Q3 2025, which was down 4.29% from -$8.8 million recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Net Income ranged from a high of -$8.8 million in Q1 2025 and a low of -$62.8 million during Q4 2021.
  • Its 3-year average for Net Income is -$11.7 million, with a median of -$9.6 million in 2024.
  • Per our database at Business Quant, Assembly Biosciences' Net Income tumbled by 461.45% in 2021 and then surged by 52.10% in 2024.
  • Over the past 4 years, Assembly Biosciences' Net Income (Quarterly) stood at -$62.8 million in 2021, then reached -$11.0 million in 2023, then grew by 5.72% to -$10.3 million in 2024, then rose by 4.34% to -$9.2 million in 2025.
  • Its Net Income was -$9.2 million in Q3 2025, compared to -$8.8 million in Q2 2025 and -$8.8 million in Q1 2025.